Influence of body mass index on semen quality: Examining sperm DNA fragmentation, protamine deficiency, and hormonal profiles

Abstract

Objective: To investigate whether differences exist in DNA fragmentation levels and protamine deficiency in the sperm of obese men compared to those of overweight and proven fertile, normal weight men and evaluate the alterations related to reproductive hormones, semen parameters and their association with body mass index (BMI).

Methods: Participants in this observational study were divided into three groups based on their BMI: proven fertile, normal weight men (n=200); overweight men (n=200); and obese men (n=200). After 3 days of abstinence, seminal fluid was collected from all participants and analyzed. Blood samples were also collected on the same day for hormonal analysis. Sperm DNA fragmentation and protamine deficiency were also assessed.

Results: A total of 600 men with a mean age of (34.3±7.9) years were included in the study. Obese males (BMI 30 kg/m² or higher) exhibited significant reductions in semen volume, sperm concentration, total sperm motility percentage, progressive motility, non-progressive motility, and levels of total testosterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) compared to overweight (BMI 25 to 29.9 kg/m²) and normal weight males (BMI 18.5 to 24.9 kg/m²) (P<0.001). Conversely, obese males showed a significant increase in prolactin level, sperm DNA fragmentation, and protamine deficiency compared to overweight and normal weight males (P<0.001). Significant negative correlations were demonstrated between BMI and sperm concentration, motility, total testosterone, FSH and LH (P<0.001), whereas prolactin, sperm DNA fragmentation and protamine deficiency were positively correlated with BMI (P<0.001).

Conclusions: This study provides clear evidence that obesity contributes potentially to male infertility by inducing sperm DNA fragmentation and protamine deficiency, as well as negatively impacting reproductive hormones and semen quality.

Conflict of interest statement

The authors declare that there is no conflict of interest.

Funding

The study received no extramural funding

Authors’ contributions

Mohammed M. Laqqan and Maged M. Yassin contributed equally to the conceptualization, formal analysis, and visualization. Maged M. Yassin led the data curation, investigation, methodology, and writing of the original draft, while Mohammed M. Laqqan provided support in data curation and contributed to the review and editing of the manuscript.

Publisher’s Note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

[1] Qasim A, Turcotte M, de Souza RJ, Samaan MC, Champredon D, Dushoff J, et al. On the origin of obesity: Identifying the biological, environmental and cultural drivers of genetic risk among human populations. Obes Rev 2018; 19(2):121-149.

[2] Munir M, Zakaria ZA, Baig AA, Mohamad MB, Arshed N, Alhajj R. Global impact on human obesity-A robust non-linear panel data analysis. Nutr Health 2024; 30(3):531-548.

[3] Park H, Choi JE, Jun S, Lee H, Kim HS, Lee HA, et al. Metabolic complications of obesity in children and adolescents. Clin Exp Pediatr 2024; 67(7):347-355.

[4] Costanian C, Bennett K, Hwalla N, Assaad S, Sibai AM. Prevalence, correlates and management of type 2 diabetes mellitus in Lebanon: Findings from a national population-based study. Diabetes Res Clin Pract 2014; 105(3):408-415.

[5] Raad G, Azouri J, Rizk K, Zeidan NS, Azouri J, Grandjean V, et al. Adverse effects of paternal obesity on the motile spermatozoa quality. PLoS One 2019; 14(2):e0211837.

[6] Vozdova M, Kubickova S, Kopecka V, Sipek J, Rubes J. Effect of body mass index on semen quality, sperm chromatin integrity and sperm DNA methylation. Obes Res Clin Pract 2024; 18(5):380-387.

[7] Fariello RM, Pariz JR, Spaine DM, Cedenho AP, Bertolla RP, Fraietta R. Association between obesity and alteration of sperm DNA integrity and mitochondrial activity. BJU Int 2012; 110(6):863-867.

[8] Genchi VA, Rossi E, Lauriola C, D’Oria R, Palma G, Borrelli A, et al. Adipose tissue dysfunction and obesity-related male hypogonadism. Int J Mol Sci 2022; 23(15):8194.

[9] Kahn BE, Brannigan RE. Obesity and male infertility. Curr Opin Urol 2017; 27(5):441-445.

[10] MacDonald A, Herbison GP, Showell M, Farquhar CM. The impact of body mass index on semen parameters and reproductive hormones in human males: A systematic review with meta-analysis. Hum Reprod Update 2010; 16(3):293-311.

[11] Anifandis G, Dafopoulos K, Messini CI, Polyzos N, Messinis IE. The BMI of men and not sperm parameters impact on embryo quality and the IVF outcome. Andrology 2013; 1(1):85-89.

[12] Nikolic AZ, Dragojevic-Dikic S, Kocic J, Babic U, Joksimovic A, Radakovic-Cosic J, et al. Influence of male body mass index on semen analysis parameters and in vitro fertilization outcomes. Medicine 2024; 103(31):e38949.

[13] Alam K, Kumar T, Jha K, Zabihullah M, Alam Sr MK. Impact of body mass index and anthropometric measures on cardiorespiratory fitness in non-obese adult males: A cross-sectional observational study. Cureus 2024; 16(12):e75329. doi: 10.7759/cureus.75329.

[14] Chung E, Arafa M, Boitrelle F, Kandil H, Henkel R, Saleh R, et al. The new 6th edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen: Is it a step toward better standard operating procedure? Asian J Androl 2022; 24(2):123-124.

[15] Laqqan MM, Yassin MM. Potential effect of tobacco cigarettes smoking on global DNA methylation status and protamines transcripts in human spermatozoa. Middle East Fertil Soc J 2021; 26(1):21.

[16] Martins AD, Majzoub A, Agawal A. Metabolic syndrome and male fertility. World J Mens Health 2019; 37(2):113-127.

[17] Agarwal A, Baskaran S, Parekh N, Cho CL, Henkel R, Vij S, et al. Male infertility. Lancet 2021; 397(10271):319-333.

[18] Potabattula R, Dittrich M, Schorsch M, Hahn T, Haaf T, El Hajj N. Male obesity effects on sperm and next-generation cord blood DNA methylation. PloS One 2019; 14(6):e0218615.

[19] Li Y, Lin Y, Ou C, Xu R, Liu T, Zhong Z, et al. Association between body mass index and semen quality: A systematic review and meta-analysis. Int J Obes (Lond) 2024; 48(10):1383-1401.

[20] Maghsoumi-Norouzabad L, Zare Javid A, Aiiashi S, Hosseini SA, Dadfar M, Bazyar H, et al. The impact of obesity on various semen parameters and sex hormones in Iranian men with infertility: A cross-sectional study. Res Rep Urol 2020; 12:357-365.

[21] Chojnacka K, Bilinska B, Mruk DD. Interleukin 1alpha-induced disruption of the Sertoli cell cytoskeleton affects gap junctional communication. Cell Signal 2016; 28(5):469-480.

[22] Tunc O, Bakos HW, Tremellen K. Impact of body mass index on seminal oxidative stress. Andrologia 2011; 43(2):121-128.

[23] Wang S, Sun J, Wang J, Ping Z, Liu L. Does obesity based on body mass index affect semen quality? A meta‐analysis and systematic review from the general population rather than the infertile population. Andrologia 2021; 53(7):e14099.

[24] Peel A, Saini A, Deluao JC, McPherson NO. Sperm DNA damage: The possible link between obesity and male infertility, an update of the current literature. Andrology 2023; 11(8):1635-1652.

[25] Nowicka-Bauer K, Nixon B. Molecular changes induced by oxidative stress that impair human sperm motility. Antioxidants 2020; 9(2):134.

[26] Cooper LA, Page ST, Amory JK, Anawalt BD, Matsumoto AM. The association of obesity with sex hormone‐binding globulin is stronger than the association with ageing-implications for the interpretation of total testosterone measurements. Clin Endocrinol 2015; 83(6):828-833.

[27] Colleluori G, Chen R, Turin CG, Vigevano F, Qualls C, Johnson B, et al. Aromatase inhibitors plus weight loss improves the hormonal profile of obese hypogonadal men without causing major side effects. Front Endocrinol 2020; 11:277.

[28] Xu X, Sun M, Ye J, Luo D, Su X, Zheng D, et al. The effect of aromatase on the reproductive function of obese males. Horm Metab Res 2017; 49(8):572-579.

[29] Leisegang K, Sengupta P, Agarwal A, Henkel R. Obesity and male infertility: Mechanisms and management. Andrologia 2021; 53(1):e13617.

[30] Di Nisio A, Sabovic I, De Toni L, Rocca MS, Dall’Acqua S, Azzena B, et al. Testosterone is sequestered in dysfunctional adipose tissue, modifying androgen-responsive genes. Int J Obes 2020; 44(7):1617-1625.

[31] Bansal S, Mundkur A, Adiga P, Kumar P, Kumar S, Poojary V, et al. The effect of body mass index on semen quality. Int J Infertil Fetal Med 2022; 13(3):121-124.

[32] Bieniek JM, Kashanian JA, Deibert CM, Grober ED, Lo KC, Brannigan RE, et al. Influence of increasing body mass index on semen and reproductive hormonal parameters in a multi-institutional cohort of subfertile men. Fertil Steril 2016; 106(5):1070-1075.

[33] Baydilli N, Selvi İ, Akınsal EC, Zararsız GE, Ekmekçioğlu O. How does body mass index affect semen parameters and reproductive hormones in infertile males? Turk J Urol 2020; 46(2):101-107.

[34] Zhu G, Zhang Y, Dong J, Liu Y, Zhao F, Li T, et al. Association between body mass index and male sperm apoptosis and apoptosis-related factors. Diabetes Metab Syndr Obes 2021; 14:1043-1051.

[35] Rato L, Alves MG, Cavaco JE, Oliveira PF. High‐energy diets: A threat for male fertility? Obes Rev 2014; 15(12):996-1007.

[36] Kurkowska W, Bogacz A, Janiszewska M, Gabry E, Tiszler M, Bellanti F, et al. Oxidative stress is associated with reduced sperm motility in normal semen. Am J Mens Health 2020; 14(5):1557988320939731. doi: 10.1177/1557988320939731.

[37] Dutta S, Sengupta P, Biswas A. Adiponectin in male reproduction and infertility. Asian Pac J Reprod 2019; 8(5):244-250.

[38] Chen YA, Chang HC, Liao CH. The impact of obesity on serum testosterone levels and semen quality in a population of infertile men. Urol Sci 2019; 30(3):118-123.

[39] Oduwole OO, Peltoketo H, Huhtaniemi IT. Role of follicle-stimulating hormone in spermatogenesis. Front Endocrinol 2018; 9:763.

[40] Palmer NO, Bakos HW, Fullston T, Lane M. Impact of obesity on male fertility, sperm function and molecular composition. Spermatogenesis 2012; 2(4):253-263.

[41] Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol 2001; 165(3):837-841.

[42] Al Sabie F, Tariq Z, Erickson D, Donegan D. Association between prolactinoma and body mass index. Endocr Pract 2021; 27(4):312-317.